Topiramate is prescribed for two very different reasons, seizure control and migraine prevention, and in both cases the plain generic tablet is one of the cheapest prescriptions in American pharmacy. Medicare Part D covered 3.30 million generic topiramate claims for 691,304 people in 2024 at an average of $12.24 per claim.
The same molecule also sits inside some of the most expensive fills on any pharmacy shelf. Brand Topamax averaged $1,922.19 per Part D claim in 2024, Trokendi XR averaged $1,837.47 and Qudexy XR averaged $1,818.96. This guide covers the cash price of generic topiramate, brand Topamax and the extended-release brands, with September 2026 prices and the federal acquisition data behind them.
What Does Topiramate Cost Without Insurance?
The Low column is what a pharmacy pays to acquire the drug, from the CMS National Average Drug Acquisition Cost file with an August 19, 2026 effective date, still present in the September 2, 2026 weekly release. The Average and High columns are cash-payer prices read on September 4, 2026.
| Topiramate presentation (30 count) | Low (pharmacy cost) | Average (cash price) | High (brand or retail) |
|---|---|---|---|
| Generic tablets, 25 mg | $0.77 | $5.74 | $165.11 (brand Topamax) |
| Generic tablets, 50 mg | $1.05 | $6.70 | $249.56 (brand Topamax) |
| Generic tablets, 100 mg | $1.65 | $8.42 | $343.69 (brand Topamax) |
| Generic tablets, 200 mg | $3.29 | $11.30 | $13.39 |
| Extended-release capsules, 100 mg | $161.46 | $166.05 | $1,072.51 (Trokendi XR) |
Cost Plus Drugs sits at or below the Average column on tablets. On September 4, 2026 it listed thirty 25 mg tablets at $5.45 against a stated retail comparison of $24.60, and thirty 100 mg tablets at $5.90 against a stated retail comparison of $73.80. Shipping is added at checkout, listed as $5.25 in the cost breakdown on those pages.
The extended-release row is where the money is. Cost Plus listed the generic extended-release sprinkle capsule (the generic of Qudexy XR) at 100 mg for $166.05 per 30, against its stated retail comparison of $846.00. Brand Qudexy XR Sprinkle was $746.85 for the same 30 capsules at Drugs.com and Trokendi XR was $1,072.51. All three are the same active ingredient as the $5.90 tablet.
What Drives the Price
Immediate-release versus extended-release
This is the single biggest driver. The August 19, 2026 acquisition file prices a 100 mg plain tablet at $0.05502 per tablet and a 100 mg extended-release capsule at $10.20028, a gap of about 185 times. The extended-release sprinkle capsule sits in between at $5.38194. Thirty extended-release capsules cost a pharmacy $306.01 to buy, before any markup at all.
Brand versus generic
Brand Topamax carries a large premium over identical generic tablets. Drugs.com listed thirty 100 mg Topamax tablets at $128.23 to $343.69 on September 4, 2026, against $8.42 for the generic. Unless the prescriber has written “dispense as written,” pharmacies substitute the generic by default.
Tablet versus sprinkle capsule
Sprinkle capsules exist for people who cannot swallow tablets, and they cost roughly ten times more per dose. In the acquisition file a 25 mg sprinkle capsule costs $0.25470 against $0.02563 for the 25 mg tablet. Drugs.com listed sixty 25 mg sprinkle capsules at $32.31 against $6.64 to $9.67 for sixty 25 mg tablets.
The 50 mg sprinkle capsule is the outlier inside the outlier. It costs a pharmacy $4.34817 per capsule in the August 19, 2026 file, so thirty of them cost $130.45 to buy, and Drugs.com listed thirty at $130.48 on September 4, 2026. That is a near-zero-margin fill on a product that costs more than twenty times what two 25 mg tablets of the same drug would.
Oral solution
The liquid is the most volatile presentation. The August 19, 2026 file carries two different acquisition costs for the 25 mg per mL oral solution, $1.08260 and $2.11842 per milliliter, which is an unusually wide spread within a single vintage. At retail, Drugs.com listed 120 mL at $259.94 and 473 mL at $590.59 the same week. If a liquid is prescribed, price it specifically rather than assuming it tracks the tablet.
Pharmacy markup on a near-free tablet
At two to five cents of drug per tablet, everything else on the receipt is dispensing cost. SingleCare put the average retail price of sixty 25 mg tablets at $121.11 while quoting $7.99 for the identical fill with its card. That fifteen-fold spread is entirely pharmacy pricing.
Cash Price vs. Insurance
For plain topiramate tablets, paying cash almost always beats using coverage. A single-digit cash fill is usually below a standard deductible-phase copay, and it avoids prior-authorization friction entirely. Pharmacies can quote you the cash price on request.
Extended-release capsules flip the calculation. At $166.05 for a generic extended-release fill and up to $1,464.25 for brand Trokendi XR at 200 mg, these are expensive enough that a covered copay is likely cheaper, and expensive enough that the fill moves your deductible meaningfully. If you have coverage and the prescription is for an extended-release product, run it through the plan before paying cash.
Remember that cash fills paid outside a plan generally do not count toward your deductible or out-of-pocket maximum. On a $6 tablet fill that is irrelevant. On a $1,000 capsule fill it is the whole decision.
How to Pay Less
Ask whether the plain tablet will do. Immediate-release tablets, extended-release capsules and sprinkle capsules are all topiramate, and they differ in price by two orders of magnitude. Whether the extended-release form is clinically necessary is a question for your prescriber, but it is worth asking before the prescription is sent rather than after you see the price.
Price a discount card against the counter price. The retail-to-card spread on topiramate is one of the widest on any common generic. Our GoodRx vs. SingleCare comparison covers how the cards differ, and our fair price checker shows what a reasonable cash price for this drug looks like before you get to the pharmacy.
Use mail order for a maintenance prescription. Topiramate for seizures or migraine prevention is a long-term fill, which is exactly the case where mail-order pharmacies win. Cost Plus Drugs listed thirty 25 mg tablets at $5.45 on September 4, 2026 with shipping added at checkout.
Ask for 90 days at a time. Drugs.com listed 25 mg tablets at $0.19 to $0.29 each at 30 count and $0.07 each at 180 count on September 4, 2026. The dispensing fee is charged per fill, so fewer fills means a lower unit price.
Challenge an extended-release bill before you pay it. If you were switched to an extended-release product and billed several hundred dollars, ask the pharmacy to run the generic extended-release sprinkle and the plain tablet as separate quotes so you can see all three prices side by side. If the charge came through a hospital or clinic pharmacy, our guides to reading an itemized hospital bill and negotiating medical bills apply.
Get the prescription from a sliding-scale clinic if cost is the barrier. Federally qualified health centers charge on income and many dispense common generics in house. See free clinics and sliding-scale care.
Bottom Line
A month of generic topiramate tablets should cost a cash payer between about $5 and $13 in September 2026. If you are being charged more than about $25 for plain tablets, the price is coming from the pharmacy counter rather than the medicine, and a different pharmacy or a discount card will close the gap.
The expensive versions of this drug are the extended-release capsules and brand Topamax, which run $71.80 to $1,464.25 for 30 doses of the same active ingredient. If your prescription is for a weight-management combination rather than plain topiramate, see our Qsymia cost guide. For related cash prices, see our guides to sumatriptan costs, lamotrigine costs, gabapentin costs and Zofran and ondansetron costs.